BioCentury
ARTICLE | Company News

Avecia, Boston BioSystems Inc. deal

August 9, 1999 7:00 AM UTC

Avecia acquired Boston BioSystems, which manufactures oligonucleotides for clinical development and DNA medicines, for $6 million in cash. ...